PTK2 and cancer: On the contrary, small molecules endowed with the capacity to simultaneously target two or more proteins involved at intracellular level in the same signalling pathways, such as VEGFR/FAK/Src/PI3K, might represent an alternative approach to treat cancer, in association with recombinant-protein and selective kinase inhibitors.